Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Grebennik, D.O.

Refine Results

Resource Type

Availability

Faculty

Author

Language

Search results

  • RSS Feed
(1 - 2 of 2)
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
Kim, Y.H.; Bagot, M.; Pinter-Brown, L.; Rook, A.H.; Porcu, P.; Horwitz, S.M.; ... ; MAVORIC Investigators 2018
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
Article / Letter to editor
metadata only
An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours
Schoffski, P.; Adkins, D.; Blay, J.Y.; Gil, T.; Elias, A.D.; Rutkowski, P.; ... ; Grebennik, D.O. 2013
An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours
Article / Letter to editor
metadata only